Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Infect Immun ; 82(3): 1030-5, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24343647

ABSTRACT

Oropharyngeal candidiasis (OPC; thrush) is an opportunistic fungal infection caused by the commensal microbe Candida albicans. Immunity to OPC is strongly dependent on CD4+ T cells, particularly those of the Th17 subset. Interleukin-17 (IL-17) deficiency in mice or humans leads to chronic mucocutaneous candidiasis, but the specific downstream mechanisms of IL-17-mediated host defense remain unclear. Lipocalin 2 (Lcn2; 24p3; neutrophil gelatinase-associated lipocalin [NGAL]) is an antimicrobial host defense factor produced in response to inflammatory cytokines, particularly IL-17. Lcn2 plays a key role in preventing iron acquisition by bacteria that use catecholate-type siderophores, and lipocalin 2(-/-) mice are highly susceptible to infection by Escherichia coli and Klebsiella pneumoniae. The role of Lcn2 in mediating immunity to fungi is poorly defined. Accordingly, in this study, we evaluated the role of Lcn2 in immunity to oral infection with C. albicans. Lcn2 is strongly upregulated following oral infection with C. albicans, and its expression is almost entirely abrogated in mice with defective IL-17 signaling (IL-17RA(-/-) or Act1(-/-) mice). However, Lcn2(-/-) mice were completely resistant to OPC, comparably to wild-type (WT) mice. Moreover, Lcn2 deficiency mediated protection from OPC induced by steroid immunosuppression. Therefore, despite its potent regulation during C. albicans infection, Lcn2 is not required for immunity to mucosal candidiasis.


Subject(s)
Acute-Phase Proteins/metabolism , Candidiasis, Oral/immunology , Candidiasis, Oral/metabolism , Interleukin-17/metabolism , Lipocalins/metabolism , Oncogene Proteins/metabolism , Acute-Phase Proteins/genetics , Acute-Phase Proteins/immunology , Animals , Candida albicans/immunology , Candidiasis, Oral/genetics , Candidiasis, Oral/microbiology , Interleukin-17/genetics , Interleukin-17/immunology , Lipocalin-2 , Lipocalins/genetics , Lipocalins/immunology , Mice , Mice, Inbred C57BL , Mouth Mucosa/immunology , Mouth Mucosa/metabolism , Mouth Mucosa/microbiology , Mucous Membrane/immunology , Mucous Membrane/metabolism , Mucous Membrane/microbiology , Oncogene Proteins/genetics , Oncogene Proteins/immunology , Receptors, Interleukin-17/genetics , Receptors, Interleukin-17/immunology , Receptors, Interleukin-17/metabolism , Up-Regulation/genetics , Up-Regulation/immunology
2.
J Infect Dis ; 209(6): 865-75, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24072844

ABSTRACT

Influenza A represents a significant cause of morbidity and mortality worldwide. Bacterial complications of influenza A confer the greatest risk to patients. TH17 pathway inhibition has been implicated as a mechanism by which influenza A alters bacterial host defense. Here we show that preceding influenza causes persistent Staphylococcus aureus infection and suppression of TH17 pathway activation in mice. Influenza does not inhibit S. aureus binding and uptake by phagocytic cells but instead attenuates S. aureus induced TH17 related antimicrobial peptides necessary for bacterial clearance in the lung. Importantly, exogenous lipocalin 2 rescued viral exacerbation of S. aureus infection and decreased free iron levels in the bronchoalveolar lavage from mice coinfected with S. aureus and influenza. These findings indicate a novel mechanism by which influenza A inhibits TH17 immunity and increases susceptibility to secondary bacterial pneumonia. Identification of new mechanisms in the pathogenesis of bacterial pneumonia could lead to future therapeutic targets.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Influenza A virus/immunology , Orthomyxoviridae Infections/microbiology , Pneumonia, Staphylococcal/microbiology , Staphylococcus aureus/immunology , Analysis of Variance , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/microbiology , Bronchoalveolar Lavage Fluid/virology , Coinfection/microbiology , Coinfection/virology , Host-Pathogen Interactions/immunology , Influenza A virus/pathogenicity , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL , Neutrophils/immunology , Orthomyxoviridae Infections/immunology , Orthomyxoviridae Infections/virology , Pneumonia, Staphylococcal/immunology , Pneumonia, Staphylococcal/virology , Staphylococcus aureus/pathogenicity , Th17 Cells
3.
Am J Pathol ; 182(5): 1519-31, 2013 May.
Article in English | MEDLINE | ID: mdl-23499554

ABSTRACT

Epithelial host defense proteins comprise a critical component of the pulmonary innate immune response to infection. The short palate, lung, nasal epithelium clone (PLUNC) 1 (SPLUNC1) protein is a member of the bactericidal/permeability-increasing (BPI) fold-containing (BPIF) protein family, sharing structural similarities with BPI-like proteins. SPLUNC1 is a 25 kDa secretory protein that is expressed in nasal, oropharyngeal, and lung epithelia, and has been implicated in airway host defense against Pseudomonas aeruginosa and other organisms. SPLUNC1 is reported to have surfactant properties, which may contribute to anti-biofilm defenses. The objective of this study was to assess the importance of SPLUNC1 surfactant activity in airway epithelial secretions and to explore its biological relevance in the context of a bacterial infection model. Using cultured airway epithelia, we confirmed that SPLUNC1 is critically important for maintenance of low surface tension in airway fluids. Furthermore, we demonstrated that recombinant SPLUNC1 (rSPLUNC1) significantly inhibited Klebsiella pneumoniae biofilm formation on airway epithelia. We subsequently found that Splunc1(-/-) mice were significantly more susceptible to infection with K. pneumoniae, confirming the likely in vivo relevance of this anti-biofilm effect. Our data indicate that SPLUNC1 is a crucial component of mucosal innate immune defense against pulmonary infection by a relevant airway pathogen, and provide further support for the novel hypothesis that SPLUNC1 protein prevents bacterial biofilm formation through its ability to modulate surface tension of airway fluids.


Subject(s)
Glycoproteins/metabolism , Host-Pathogen Interactions/immunology , Klebsiella Infections/immunology , Klebsiella pneumoniae/physiology , Lung/pathology , Phosphoproteins/metabolism , Respiratory Tract Infections/immunology , Animals , Base Sequence , Biofilms/growth & development , Cytokines/biosynthesis , Disease Susceptibility/immunology , Disease Susceptibility/microbiology , Disease Susceptibility/pathology , Disease Susceptibility/physiopathology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Glycoproteins/deficiency , Glycoproteins/genetics , Humans , Inflammation Mediators/metabolism , Klebsiella Infections/microbiology , Klebsiella Infections/pathology , Klebsiella Infections/physiopathology , Klebsiella pneumoniae/growth & development , Lung/immunology , Lung/microbiology , Lung/physiopathology , Mice , Molecular Sequence Data , Phosphoproteins/deficiency , Phosphoproteins/genetics , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/pathology , Respiratory Tract Infections/physiopathology , Surface Tension , Up-Regulation
4.
J Allergy Clin Immunol ; 131(4): 1117-29, 1129.e1-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22795370

ABSTRACT

BACKGROUND: IL-17 is an important cytokine signature of the TH differentiation pathway TH17. This T-cell subset is crucial in mediating autoimmune disease or antimicrobial immunity in animal models, but its presence and role in human disease remain to be completely characterized. OBJECTIVE: We set out to determine the frequency of TH17 cells in patients with cystic fibrosis (CF), a disease in which there is recurrent infection with known pathogens. METHODS: Explanted lungs from patients undergoing transplantation or organ donors (CF samples=18; non-CF, nonbronchiectatic samples=10) were collected. Hilar nodes and parenchymal lung tissue were processed and examined for TH17 signature by using immunofluorescence and quantitative real-time PCR. T cells were isolated and stimulated with antigens from Pseudomonas aeruginosa and Aspergillus species. Cytokine profiles and staining with flow cytometry were used to assess the reactivity of these cells to antigen stimulation. RESULTS: We found a strong IL-17 phenotype in patients with CF compared with that seen in control subjects without CF. Within this tissue, we found pathogenic antigen-responsive CD4+IL-17+ cells. There were double-positive IL-17+IL-22+ cells [TH17(22)], and the IL-22+ population had a higher proportion of memory characteristics. Antigen-specific TH17 responses were stronger in the draining lymph nodes compared with those seen in matched parenchymal lungs. CONCLUSION: Inducible proliferation of TH17(22) with memory cell characteristics is seen in the lungs of patients with CF. The function of these individual subpopulations will require further study regarding their development. T cells are likely not the exclusive producers of IL-17 and IL-22, and this will require further characterization.


Subject(s)
Cystic Fibrosis/pathology , Interleukin-17/immunology , Interleukins/immunology , Lung/pathology , Lymph Nodes/pathology , Th17 Cells/pathology , Adult , Aged , Antigens, Bacterial/immunology , Antigens, Bacterial/pharmacology , Antigens, Fungal/immunology , Antigens, Fungal/pharmacology , Aspergillus/chemistry , Case-Control Studies , Cell Proliferation/drug effects , Cystic Fibrosis/genetics , Cystic Fibrosis/immunology , Female , Gene Expression , Humans , Immunologic Memory , Immunophenotyping , Interleukin-17/genetics , Interleukins/genetics , Lung/drug effects , Lung/immunology , Lymph Nodes/drug effects , Lymph Nodes/immunology , Lymphocyte Activation/drug effects , Male , Middle Aged , Pseudomonas aeruginosa/chemistry , Th17 Cells/drug effects , Th17 Cells/immunology , Interleukin-22
5.
PLoS One ; 7(11): e50052, 2012.
Article in English | MEDLINE | ID: mdl-23185529

ABSTRACT

Pulmonary tuberculosis (TB), caused by the intracellular bacteria Mycobacterium tuberculosis, is a worldwide disease that continues to kill more than 1.5 million people every year worldwide. The accumulation of lymphocytes mediates the formation of the tubercle granuloma in the lung and is crucial for host protection against M.tuberculosis infection. However, paradoxically the tubercle granuloma is also the basis for the immunopathology associated with the disease and very little is known about the regulatory mechanisms that constrain the inflammation associated with the granulomas. Lipocalin 2 (Lcn2) is a member of the lipocalin family of proteins and binds to bacterial siderophores thereby sequestering iron required for bacterial growth. Thus far, it is not known whether Lcn2 plays a role in the inflammatory response to mycobacterial pulmonary infections. In the present study, using models of acute and chronic mycobacterial pulmonary infections, we reveal a novel role for Lcn2 in constraining T cell lymphocytic accumulation and inflammation by inhibiting inflammatory chemokines, such as CXCL9. In contrast, Lcn2 promotes neutrophil recruitment during mycobacterial pulmonary infection, by inducing G-CSF and KC in alveolar macrophages. Importantly, despite a common role for Lcn2 in regulating chemokines during mycobacterial pulmonary infections, Lcn2 deficient mice are more susceptible to acute M.bovis BCG, but not low dose M.tuberculosis pulmonary infection.


Subject(s)
Acute-Phase Proteins/immunology , Granuloma, Respiratory Tract/veterinary , Lipocalins/immunology , Mycobacterium Infections/veterinary , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/immunology , Oncogene Proteins/immunology , Tuberculosis/veterinary , Acute Disease , Acute-Phase Proteins/deficiency , Acute-Phase Proteins/genetics , Animals , Cell Movement , Chemokine CXCL9/antagonists & inhibitors , Chemokine CXCL9/immunology , Chronic Disease , Gene Expression , Granuloma, Respiratory Tract/immunology , Granuloma, Respiratory Tract/metabolism , Granuloma, Respiratory Tract/microbiology , Inflammation/immunology , Inflammation/metabolism , Inflammation/microbiology , Inflammation/veterinary , Iron/metabolism , Lipocalin-2 , Lipocalins/genetics , Macrophages, Alveolar/immunology , Macrophages, Alveolar/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mycobacterium Infections/immunology , Mycobacterium Infections/metabolism , Mycobacterium Infections/microbiology , Neutrophils/immunology , Neutrophils/microbiology , Oncogene Proteins/deficiency , Oncogene Proteins/genetics , Siderophores/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/microbiology , Tuberculosis/immunology , Tuberculosis/metabolism , Tuberculosis/microbiology
6.
Infect Immun ; 80(1): 410-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22038916

ABSTRACT

We have previously reported that mice deficient in the beta-glucan receptor Dectin-1 displayed increased susceptibility to Aspergillus fumigatus lung infection in the presence of lower interleukin 23 (IL-23) and IL-17A production in the lungs and have reported a role for IL-17A in lung defense. As IL-23 is also thought to control the production of IL-22, we examined the role of Dectin-1 in IL-22 production, as well as the role of IL-22 in innate host defense against A. fumigatus. Here, we show that Dectin-1-deficient mice demonstrated significantly reduced levels of IL-22 in the lungs early after A. fumigatus challenge. Culturing cells from enzymatic lung digests ex vivo further demonstrated Dectin-1-dependent IL-22 production. IL-22 production was additionally found to be independent of IL-1ß, IL-6, or IL-18 but required IL-23. The addition of recombinant IL-23 augmented IL-22 production in wild-type (WT) lung cells and rescued IL-22 production by lung cells from Dectin-1-deficient mice. In vivo neutralization of IL-22 in the lungs of WT mice resulted in impaired A. fumigatus lung clearance. Moreover, mice deficient in IL-22 also demonstrated a higher lung fungal burden after A. fumigatus challenge in the presence of impaired IL-1α, tumor necrosis factor alpha (TNF-α), CCL3/MIP-1α, and CCL4/MIP-1ß production and lower neutrophil recruitment, yet intact IL-17A production. We further show that lung lavage fluid collected from both A. fumigatus-challenged Dectin-1-deficient and IL-22-deficient mice had compromised anti-fungal activity against A. fumigatus in vitro. Although lipocalin 2 production was observed to be Dectin-1 and IL-22 dependent, lipocalin 2-deficient mice did not demonstrate impaired A. fumigatus clearance. Moreover, lung S100a8, S100a9, and Reg3g mRNA expression was not lower in either Dectin-1-deficient or IL-22-deficient mice. Collectively, our results indicate that early innate lung defense against A. fumigatus is mediated by Dectin-1-dependent IL-22 production.


Subject(s)
Aspergillus fumigatus/immunology , Interleukins/immunology , Lectins, C-Type/metabolism , Lung/immunology , Pulmonary Aspergillosis/immunology , Animals , Bronchoalveolar Lavage Fluid/immunology , Cells, Cultured , Colony Count, Microbial , Lectins, C-Type/deficiency , Lung/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/immunology , Interleukin-22
7.
Cytokine ; 56(2): 435-41, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21855366

ABSTRACT

Lipocalin 2 is a protein that has garnered a great deal of interest in multidisciplinary fields over the last two decades since its discovery. However, its exact function in metabolic processes remains to be completely characterized. More recently, it has come to light as a highly upregulated protein in the setting of injury and infection. This review focuses on lipocalin 2 regulation and its relationship to cytokine and endocrine signaling pathways.


Subject(s)
Acute-Phase Proteins/physiology , Inflammation/physiopathology , Lipocalins/physiology , Neoplasms/physiopathology , Proto-Oncogene Proteins/physiology , Acute-Phase Proteins/genetics , Acute-Phase Proteins/metabolism , Base Sequence , DNA , Disease Progression , Humans , Lipocalin-2 , Lipocalins/genetics , Lipocalins/metabolism , Molecular Sequence Data , Promoter Regions, Genetic , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Signal Transduction
8.
PLoS One ; 6(5): e20333, 2011.
Article in English | MEDLINE | ID: mdl-21647421

ABSTRACT

Chronic Obstructive Pulmonary Disease (COPD) is characterized by airspace enlargement and peribronchial lymphoid follicles; however, the immunological mechanisms leading to these pathologic changes remain undefined. Here we show that cigarette smoke is a selective adjuvant that augments in vitro and in vivo Th17, but not Th1, cell differentiation via the aryl hydrocarbon receptor. Smoke exposed IL-17RA(-/-) mice failed to induce CCL2 and MMP12 compared to WT mice. Remarkably, in contrast to WT mice, IL-17RA(-/-) mice failed to develop emphysema after 6 months of cigarette smoke exposure. Taken together, these data demonstrate that cigarette smoke is a potent Th17 adjuvant and that IL-17RA signaling is required for chemokine expression necessary for MMP12 induction and tissue emphysema.


Subject(s)
Chemokine CCL2/metabolism , Emphysema/immunology , Gene Expression Regulation/immunology , Macrophages/immunology , Nicotiana/immunology , Receptors, Interleukin-17/metabolism , Smoke/adverse effects , Adjuvants, Immunologic/pharmacology , Animals , Bronchi/cytology , Bronchoalveolar Lavage , Cell Differentiation/immunology , Chemokine CCL2/genetics , Emphysema/etiology , Emphysema/metabolism , Female , Humans , Macrophages/metabolism , Matrix Metalloproteinase 12/genetics , Matrix Metalloproteinase 3/genetics , Mice , Mucous Membrane/immunology , Mucous Membrane/metabolism , Receptors, Aryl Hydrocarbon/metabolism , Sequence Analysis, RNA , Th17 Cells/cytology , Th17 Cells/immunology , Transcriptional Activation/immunology
9.
J Clin Invest ; 120(9): 3242-54, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20714107

ABSTRACT

Allergic bronchopulmonary aspergillosis (ABPA) is caused by a dominant Th2 immune response to antigens derived from the opportunistic mold Aspergillus, most commonly Aspergillus fumigatus. It occurs in 4%-15% of patients with cystic fibrosis (CF); however, not all patients with CF infected with A. fumigatus develop ABPA. Therefore, we compared cohorts of A. fumigatus-colonized CF patients with and without ABPA to identify factors mediating tolerance versus sensitization. We found that the costimulatory molecule OX40 ligand (OX40L) was critical in driving Th2 responses to A. fumigatus in peripheral CD4+ T cells isolated from patients with ABPA. In contrast, CD4+ T cells from the non-ABPA cohort did not mount enhanced Th2 responses in vitro and contained a higher frequency of TGF-beta-expressing regulatory T cells. Heightened Th2 reactivity in the ABPA cohort correlated with lower mean serum vitamin D levels. Further, in vitro addition of 1,25 OH-vitamin D3 substantially reduced DC expression of OX40L and increased DC expression of TGF-beta. This in vitro treatment also resulted in increased Treg TGF-beta expression and reduced Th2 responses by CD4+ T cells from patients with ABPA. These data provide rationale for a therapeutic trial of vitamin D to prevent or treat ABPA in patients with CF.


Subject(s)
Aspergillosis, Allergic Bronchopulmonary/immunology , Aspergillus fumigatus/immunology , CD4-Positive T-Lymphocytes/immunology , Cholecalciferol/pharmacology , Cystic Fibrosis/immunology , Th2 Cells/immunology , Adult , Aspergillus/immunology , Female , Humans , Male , Receptors, OX40/metabolism , T-Lymphocytes, Regulatory/immunology , Transforming Growth Factor beta/immunology
10.
J Immunol ; 182(8): 4947-56, 2009 Apr 15.
Article in English | MEDLINE | ID: mdl-19342674

ABSTRACT

Antimicrobial proteins comprise a significant component of the acute innate immune response to infection. They are induced by pattern recognition receptors as well as by cytokines of the innate and adaptive immune pathways and play important roles in infection control and immunomodulatory homeostasis. Lipocalin 2 (siderocalin, NGAL, 24p3), a siderophore-binding antimicrobial protein, is critical for control of systemic infection with Escherichia coli; however, its role in mucosal immunity in the respiratory tract is unknown. In this study, we found that lipocalin 2 is rapidly and robustly induced by Klebsiella pneumoniae infection and is TLR4 dependent. IL-1beta and IL-17 also individually induce lipocalin 2. Mucosal administration of IL-1beta alone could reconstitute the lipocalin 2 deficiency in TLR4 knockout animals and rescue them from infection. Lipocalin 2-deficient animals have impaired lung bacterial clearance in this model and mucosal reconstitution of lipocalin 2 protein in these animals resulted in rescue of this phenotype. We conclude that lipocalin 2 is a crucial component of mucosal immune defense against pulmonary infection with K. pneumoniae.


Subject(s)
Acute-Phase Proteins/immunology , Acute-Phase Proteins/metabolism , Klebsiella Infections/immunology , Klebsiella Infections/metabolism , Lipocalins/immunology , Lipocalins/metabolism , Oncogene Proteins/immunology , Oncogene Proteins/metabolism , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/metabolism , Proto-Oncogene Proteins/metabolism , Acute-Phase Proteins/genetics , Animals , Bronchi/metabolism , Cell Line , Epithelium/metabolism , Humans , Interleukin-17/pharmacology , Interleukin-1beta/pharmacology , Klebsiella Infections/genetics , Klebsiella Infections/pathology , Lipocalin-2 , Lipocalins/genetics , Mice , Mice, Knockout , Oncogene Proteins/genetics , Pneumonia, Bacterial/genetics , Pneumonia, Bacterial/pathology , Up-Regulation/drug effects , Up-Regulation/immunology
11.
Nat Rev Immunol ; 8(11): 829-35, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18949018

ABSTRACT

Antimicrobial proteins constitute a phylogenetically ancient form of innate immunity that provides host defence at skin and mucosal surfaces. Although some components of this system are constitutively expressed, new evidence reviewed in this Progress article shows that the production of certain antimicrobial proteins by epithelial cells can also be regulated by cytokines of the innate and adaptive immune systems. In particular, the effector cytokines interleukin-17 and interleukin-22, which are produced by the T-helper-17-cell subset, are emerging as crucial regulators of antimicrobial-peptide production in the gut and the lungs. This suggests that this T-cell lineage and its cytokines have important roles in skin and mucosal immunity.


Subject(s)
Antimicrobial Cationic Peptides/immunology , Cytokines/immunology , Animals , Immunity, Innate/immunology , Immunity, Mucosal/immunology , T-Lymphocytes/immunology
12.
Nat Med ; 14(3): 275-81, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18264110

ABSTRACT

Emerging evidence supports the concept that T helper type 17 (T(H)17) cells, in addition to mediating autoimmunity, have key roles in mucosal immunity against extracellular pathogens. Interleukin-22 (IL-22) and IL-17A are both effector cytokines produced by the T(H)17 lineage, and both were crucial for maintaining local control of the Gram-negative pulmonary pathogen, Klebsiella pneumoniae. Although both cytokines regulated CXC chemokines and granulocyte colony-stimulating factor production in the lung, only IL-22 increased lung epithelial cell proliferation and increased transepithelial resistance to injury. These data support the concept that the T(H)17 cell lineage and its effector molecules have evolved to effect host defense against extracellular pathogens at mucosal sites.


Subject(s)
Immunity, Mucosal/immunology , Interleukins/immunology , Klebsiella Infections/immunology , Klebsiella pneumoniae/immunology , Animals , Cells, Cultured , Chemokines/metabolism , Cystic Fibrosis/immunology , Cystic Fibrosis/pathology , Epithelial Cells/metabolism , Humans , Interleukin-17/immunology , Interleukin-23/immunology , Interleukins/metabolism , Klebsiella pneumoniae/metabolism , Lung/metabolism , Lung/microbiology , Lymph Nodes/cytology , Male , Mice , Mice, Inbred C57BL , Neutralization Tests , Receptors, Interleukin/genetics , Receptors, Interleukin/metabolism , Respiratory Mucosa/cytology , Spleen/microbiology , T-Lymphocytes/immunology , Up-Regulation , Interleukin-22
13.
Curr Opin Infect Dis ; 20(2): 157-64, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17496574

ABSTRACT

PURPOSE OF REVIEW: Molecular techniques offer the promise of improving diagnosis of lower respiratory tract infections. This review focuses on currently used molecular diagnostic techniques for various types of pneumonia and highlights potential future applications of this technology. RECENT FINDINGS: Lower respiratory tract infections result in a high degree of morbidity and mortality, but a definitive microbiologic diagnosis is often not obtained by traditional culture or serologic methods. In addition, culture of certain organisms may be difficult or require extended periods of time. Molecular techniques have the potential to improve diagnostic yield and decrease time to pathogen identification. These techniques are also helpful in the determination of drug sensitivity and the understanding of transmission and outbreaks. Most currently used techniques employ some variation of the polymerase chain reaction. Limitations include high costs, the need for specialized equipment, and problems with false-positive and -negative results. SUMMARY: Molecular diagnosis of pneumonia has the potential to improve identification of pathogens in patients with suspected lower respiratory tract infection. Limitations of molecular techniques currently prevent their widespread use, but future developments will likely lead to inclusion of these tests in routine diagnostic evaluations.


Subject(s)
Lung Diseases, Fungal/diagnosis , Molecular Diagnostic Techniques , Pneumonia, Bacterial/diagnosis , Pneumonia, Viral/diagnosis , Humans , Lung Diseases, Fungal/genetics , Nucleic Acid Amplification Techniques , Pneumonia, Bacterial/genetics , Pneumonia, Viral/genetics , Polymerase Chain Reaction/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...